147 related articles for article (PubMed ID: 31924119)
21. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics.
Bursill CA; Channon KM; Greaves DR
Curr Opin Lipidol; 2004 Apr; 15(2):145-9. PubMed ID: 15017357
[TBL] [Abstract][Full Text] [Related]
22. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
[TBL] [Abstract][Full Text] [Related]
23. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
[TBL] [Abstract][Full Text] [Related]
24. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
Front Immunol; 2019; 10():2780. PubMed ID: 31849963
[TBL] [Abstract][Full Text] [Related]
25. Arteriolar and venular remodeling are differentially regulated by bone marrow-derived cell-specific CX3CR1 and CCR2 expression.
Meisner JK; Song J; Price RJ
PLoS One; 2012; 7(9):e46312. PubMed ID: 23029475
[TBL] [Abstract][Full Text] [Related]
26. Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy.
Qian C; Worrede-Mahdi A; Shen F; DiNatale A; Kaur R; Zhang Q; Cristofanilli M; Meucci O; Fatatis A
Mol Cancer Res; 2018 Dec; 16(12):1844-1854. PubMed ID: 30115759
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
28. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis.
Sacre K; Hunt PW; Hsue PY; Maidji E; Martin JN; Deeks SG; Autran B; McCune JM
AIDS; 2012 Apr; 26(7):805-14. PubMed ID: 22313962
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.
Rahman K; Vengrenyuk Y; Ramsey SA; Vila NR; Girgis NM; Liu J; Gusarova V; Gromada J; Weinstock A; Moore KJ; Loke P; Fisher EA
J Clin Invest; 2017 Aug; 127(8):2904-2915. PubMed ID: 28650342
[TBL] [Abstract][Full Text] [Related]
30. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease.
Wong BW; Wong D; McManus BM
Cardiovasc Pathol; 2002; 11(6):332-8. PubMed ID: 12459434
[TBL] [Abstract][Full Text] [Related]
31. Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells.
Liu X; Lu G; Shen J
Mol Biol Rep; 2011 Jan; 38(1):481-8. PubMed ID: 20364328
[TBL] [Abstract][Full Text] [Related]
32. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
Moatti D; Faure S; Fumeron F; Amara Mel-W; Seknadji P; McDermott DH; Debré P; Aumont MC; Murphy PM; de Prost D; Combadière C
Blood; 2001 Apr; 97(7):1925-8. PubMed ID: 11264153
[TBL] [Abstract][Full Text] [Related]
34. CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.
Nagashimada M; Sawamoto K; Ni Y; Kitade H; Nagata N; Xu L; Kobori M; Mukaida N; Yamashita T; Kaneko S; Ota T
Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33765141
[TBL] [Abstract][Full Text] [Related]
35. Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.
Zhang W; Choi Y; Haynes LM; Harcourt JL; Anderson LJ; Jones LP; Tripp RA
J Virol; 2010 Jan; 84(2):1148-57. PubMed ID: 19864390
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4/10 in blocking persistent inflammation.
Ha JW; You MJ; Park HS; Kim JW; Kwon MS
Arch Pharm Res; 2019 Apr; 42(4):359-368. PubMed ID: 30852731
[TBL] [Abstract][Full Text] [Related]
37. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis.
Liu Z; Condello C; Schain A; Harb R; Grutzendler J
J Neurosci; 2010 Dec; 30(50):17091-101. PubMed ID: 21159979
[TBL] [Abstract][Full Text] [Related]
38. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients.
Combadière B; Faure S; Autran B; Debré P; Combadière C
AIDS; 2003 Jun; 17(9):1279-90. PubMed ID: 12799549
[TBL] [Abstract][Full Text] [Related]
39. Orthopedic surgery-induced cognitive dysfunction is mediated by CX3CL1/R1 signaling.
Cho I; Kim JM; Kim EJ; Kim SY; Kam EH; Cheong E; Suh M; Koo BN
J Neuroinflammation; 2021 Apr; 18(1):93. PubMed ID: 33858422
[TBL] [Abstract][Full Text] [Related]
40. Icariin inhibits atherosclerosis progress in Apoe null mice by downregulating CX3CR1 in macrophage.
Wang Y; Wang YS; Song SL; Liang H; Ji AG
Biochem Biophys Res Commun; 2016 Feb; 470(4):845-50. PubMed ID: 26802470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
